supreme antacid

Generic: calcium carbonate, magnesium hydroxide

Labeler: h e b
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name supreme antacid
Generic Name calcium carbonate, magnesium hydroxide
Labeler h e b
Dosage Form LIQUID
Routes
ORAL
Active Ingredients

calcium carbonate 800 mg/10mL, magnesium hydroxide 270 mg/10mL

Manufacturer
H E B

Identifiers & Regulatory

Product NDC 37808-614
Product ID 37808-614_3ac9598f-d3bd-4529-8376-6f6038560aef
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M001
Listing Expiration 2026-12-31
Marketing Start 2025-02-07

Pharmacologic Class

Classes
blood coagulation factor [epc] calcium [cs] calculi dissolution agent [epc] cations divalent [cs] increased coagulation factor activity [pe] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] phosphate binder [epc] phosphate chelating activity [moa] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 37808614
Hyphenated Format 37808-614

Supplemental Identifiers

RxCUI
237865
UPC
0041220556335
UNII
H0G9379FGK NBZ3QY004S

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name supreme antacid (source: ndc)
Generic Name calcium carbonate, magnesium hydroxide (source: ndc)
Application Number M001 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 800 mg/10mL
  • 270 mg/10mL
source: ndc
Packaging
  • 355 mL in 1 BOTTLE (37808-614-05)
source: ndc

Packages (1)

37808-614-05 355 mL in 1 BOTTLE (37808-614-05)

Ingredients (2)

calcium carbonate (800 mg/10mL) magnesium hydroxide (270 mg/10mL)

Linked Drug Pages (1)

Supreme Antacid ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3ac9598f-d3bd-4529-8376-6f6038560aef", "openfda": {"upc": ["0041220556335"], "unii": ["H0G9379FGK", "NBZ3QY004S"], "rxcui": ["237865"], "spl_set_id": ["18a7dfd9-d927-7625-e063-6394a90a270f"], "manufacturer_name": ["H E B"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "355 mL in 1 BOTTLE (37808-614-05)", "package_ndc": "37808-614-05", "marketing_start_date": "20250207"}], "brand_name": "Supreme Antacid", "product_id": "37808-614_3ac9598f-d3bd-4529-8376-6f6038560aef", "dosage_form": "LIQUID", "pharm_class": ["Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "37808-614", "generic_name": "calcium carbonate, magnesium hydroxide", "labeler_name": "H E B", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Supreme Antacid", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "800 mg/10mL"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "270 mg/10mL"}], "application_number": "M001", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250207", "listing_expiration_date": "20261231"}